CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SC 13D/A Stake Beneficial Ownership Report
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 4 Gift Director gave 567,871 shares (gift)
- D Other Notice of Sales of Unregistered Securities
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Medical Officer acquired 3,581,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 18 of 50 · 996 filings